NASDAQ:BLPH
$1.92
(
1.59%
)
Friday, 3rd Feb 2023
Bellerophon Therapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.80 | $3.50 | Friday, 3rd Feb 2023 BLPH stock ended at $1.92. This is 1.59% more than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 6.45% from a day low at $1.86 to a day high of $1.98. |
| 90 days | $0.674 | $3.50 | |
| 52 weeks | $0.670 | $3.50 |
Historical Bellerophon Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-02-03 | $1.90 | $1.98 | $1.86 | $1.92 | 18 089 |
| 2023-02-02 | $1.75 | $1.96 | $1.74 | $1.89 | 35 085 |
| 2023-02-01 | $2.01 | $2.01 | $1.75 | $1.79 | 63 722 |
| 2023-01-31 | $1.99 | $2.00 | $1.90 | $1.94 | 35 797 |
| 2023-01-30 | $2.14 | $2.14 | $1.86 | $1.91 | 91 371 |
| 2023-01-27 | $2.09 | $2.16 | $2.06 | $2.10 | 35 667 |
| 2023-01-26 | $2.28 | $2.35 | $2.09 | $2.10 | 95 831 |
| 2023-01-25 | $2.42 | $2.46 | $2.32 | $2.35 | 28 778 |
| 2023-01-24 | $2.31 | $2.47 | $2.31 | $2.39 | 64 969 |
| 2023-01-23 | $2.38 | $2.40 | $2.24 | $2.35 | 55 587 |
| 2023-01-20 | $2.26 | $2.38 | $2.12 | $2.38 | 81 902 |
| 2023-01-19 | $2.21 | $2.33 | $2.14 | $2.26 | 271 400 |
| 2023-01-18 | $2.64 | $2.64 | $2.36 | $2.45 | 771 229 |
| 2023-01-17 | $2.47 | $2.58 | $2.38 | $2.58 | 125 828 |
| 2023-01-13 | $2.41 | $2.49 | $2.30 | $2.42 | 91 400 |
| 2023-01-12 | $2.55 | $2.55 | $2.21 | $2.33 | 133 177 |
| 2023-01-11 | $2.22 | $2.63 | $2.22 | $2.50 | 289 400 |
| 2023-01-10 | $2.27 | $2.43 | $2.21 | $2.32 | 216 500 |
| 2023-01-09 | $2.23 | $2.49 | $1.98 | $2.41 | 692 700 |
| 2023-01-06 | $1.96 | $2.64 | $1.90 | $2.43 | 3 152 400 |
| 2023-01-05 | $3.43 | $3.50 | $2.05 | $2.29 | 56 512 907 |
| 2023-01-04 | $0.98 | $0.98 | $0.80 | $0.91 | 32 003 |
| 2023-01-03 | $0.87 | $0.96 | $0.81 | $0.90 | 7 575 |
| 2022-12-30 | $0.80 | $0.94 | $0.785 | $0.90 | 38 019 |
| 2022-12-29 | $0.81 | $0.89 | $0.81 | $0.83 | 20 455 |
| 2022-12-28 | $0.793 | $0.97 | $0.793 | $0.84 | 49 235 |
| 2022-12-27 | $0.84 | $0.84 | $0.700 | $0.785 | 42 834 |
| 2022-12-23 | $0.87 | $0.88 | $0.750 | $0.750 | 94 656 |
| 2022-12-22 | $0.93 | $1.18 | $0.85 | $0.88 | 165 012 |
| 2022-12-21 | $0.780 | $1.00 | $0.730 | $0.89 | 96 912 |
| 2022-12-20 | $0.690 | $0.84 | $0.674 | $0.674 | 136 048 |
| 2022-12-19 | $0.776 | $0.89 | $0.776 | $0.81 | 51 631 |
| 2022-12-16 | $0.790 | $0.90 | $0.750 | $0.771 | 60 936 |
| 2022-12-15 | $0.81 | $0.90 | $0.795 | $0.795 | 37 480 |
| 2022-12-14 | $0.93 | $0.95 | $0.82 | $0.82 | 42 759 |
| 2022-12-13 | $0.94 | $0.96 | $0.93 | $0.93 | 14 960 |
| 2022-12-12 | $1.12 | $1.12 | $0.95 | $0.95 | 15 569 |
| 2022-12-09 | $0.93 | $0.97 | $0.92 | $0.97 | 14 217 |
| 2022-12-08 | $0.97 | $0.98 | $0.90 | $0.93 | 10 373 |
| 2022-12-07 | $1.05 | $1.05 | $0.97 | $0.97 | 10 572 |
| 2022-12-06 | $1.03 | $1.03 | $0.98 | $0.98 | 2 711 |
| 2022-12-05 | $1.04 | $1.04 | $0.98 | $0.98 | 5 239 |
| 2022-12-02 | $1.01 | $1.03 | $1.01 | $1.02 | 2 386 |
| 2022-12-01 | $0.99 | $1.05 | $0.99 | $1.02 | 12 681 |
| 2022-11-30 | $1.05 | $1.05 | $1.00 | $1.00 | 11 777 |
| 2022-11-29 | $1.00 | $1.02 | $0.98 | $1.01 | 3 129 |
| 2022-11-28 | $1.00 | $1.09 | $1.00 | $1.03 | 4 288 |
| 2022-11-25 | $1.03 | $1.03 | $1.03 | $1.03 | 1 124 |
| 2022-11-23 | $1.03 | $1.07 | $1.02 | $1.02 | 5 811 |
| 2022-11-22 | $1.05 | $1.07 | $1.05 | $1.07 | 880 |
About Bellerophon Therapeutics
Bellerophon Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its product includes INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension. The company engages in the development of INOpulse that is in Phase 3 clinical trial for the treatment of pulmonary hypertension associated w... BLPH Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
